Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by The Fifth People's Hospital of Suzhou.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
The Fifth People's Hospital of Suzhou
ClinicalTrials.gov Identifier:
NCT01380951
First received: June 23, 2011
Last updated: NA
Last verified: June 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)